Literature DB >> 25904200

Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.

Masato Muto1, Muhammad Baghdadi, Ryuji Maekawa, Haruka Wada, Ken-Ichiro Seino.   

Abstract

Human T cells expressing γδ T cell receptor have a potential to show antigen-presenting cell-like phenotype and function upon their activation. However, the mechanisms that underlie the alterations in human γδ T cells remain largely unclear. In this study, we have investigated the molecular characteristics of human γδ T cells related to their acquisition of antigen-presenting capacity in comparison with activated αβ T cells. We found that activated γδ but not αβ T cells upregulated cell surface expression of a scavenger receptor, CD36, which seemed to be mediated by signaling through mitogen-activated protein kinase and/or NF-κB pathways. Confocal microscopical analysis revealed that activated γδ T cells can phagocytose protein antigens. Activated γδ T cells could induce tumor antigen-specific CD8(+) T cells using both apoptotic and live tumor cells as antigen resources. Furthermore, we detected that C/EBPα, a critical transcription factor for the development of myeloid-lineage cells, is expressed much higher in γδ T cells than in αβ T cells. These results unveiled the molecular mechanisms for the elicitation of antigen-presenting functions in γδ T cells and would also help designing new approaches for γδ T cell-mediated human cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25904200     DOI: 10.1007/s00262-015-1700-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Lipid Metabolism in Tumor-Infiltrating T Cells.

Authors:  Shangwen He; Ting Cai; Juanjuan Yuan; Xiaojun Zheng; Wei Yang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.

Authors:  Kilian Wistuba-Hamprecht; Alexander Martens; Karin Haehnel; Marnix Geukes Foppen; Jianda Yuan; Michael A Postow; Phillip Wong; Emanuela Romano; Amir Khammari; Brigitte Dreno; Mariaelena Capone; Paolo A Ascierto; Ilja Demuth; Elisabeth Steinhagen-Thiessen; Anis Larbi; Bastian Schilling; Dirk Schadendorf; Jedd D Wolchok; Christian U Blank; Graham Pawelec; Claus Garbe; Benjamin Weide
Journal:  Eur J Cancer       Date:  2016-07-09       Impact factor: 9.162

3.  Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages.

Authors:  Moulay Yassine Belghali; Brahim Admou; Maroua Brahimi; Mouna Khouchani; Saadia Ba-M'hamed
Journal:  Immunol Res       Date:  2022-01-10       Impact factor: 2.829

Review 4.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

5.  γδ T Cells Support Antigen-Specific αβ T cell-Mediated Antitumor Responses during BCG Treatment for Bladder Cancer.

Authors:  Niannian Ji; Neelam Mukherjee; Zhen-Ju Shu; Ryan M Reyes; Joshua J Meeks; David J McConkey; Jonathan A Gelfond; Tyler J Curiel; Robert S Svatek
Journal:  Cancer Immunol Res       Date:  2021-10-04       Impact factor: 12.020

6.  Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.

Authors:  Dominic Paquin-Proulx; Nathália Silveira Barsotti; Bianca A N Santos; Ana Karolina B B Marinho; Cristina M Kokron; Karina I Carvalho; Myrthes T Barros; Jorge Kalil; Douglas F Nixon; Esper G Kallas
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 7.  Gamma-delta (γδ) T cells: friend or foe in cancer development?

Authors:  Yijing Zhao; Chao Niu; Jiuwei Cui
Journal:  J Transl Med       Date:  2018-01-10       Impact factor: 5.531

Review 8.  Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.

Authors:  Myriam Lawand; Julie Déchanet-Merville; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 9.  Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection.

Authors:  Jennifer Howard; Irfan Zaidi; Séverine Loizon; Odile Mercereau-Puijalon; Julie Déchanet-Merville; Maria Mamani-Matsuda
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

Review 10.  The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.

Authors:  Yuxia Liu; Cai Zhang
Journal:  Cells       Date:  2020-05-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.